HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liuxiang Chu Selected Research

cetyl alcohol

10/2021Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liuxiang Chu Research Topics

Disease

3Glioblastoma (Glioblastoma Multiforme)
01/2022 - 11/2018
2Glioma (Gliomas)
01/2022 - 10/2021
2Parkinson Disease (Parkinson's Disease)
12/2019 - 01/2018
2Type 2 Diabetes Mellitus (MODY)
12/2019 - 01/2019
1Diabetes Mellitus
12/2019
1Choroidal Neovascularization
11/2018
1Stomach Ulcer (Gastric Ulcer)
12/2014
1Ulcer
12/2014

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
01/2022 - 11/2018
3Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 11/2018
2Exenatide (Byetta)FDA Link
12/2019 - 01/2019
1GoldIBA
01/2022
1Therapeutic UsesIBA
01/2022
1EstersIBA
10/2021
11-hexanol (n-hexanol)IBA
10/2021
1Biological ProductsIBA
10/2021
1cetyl alcoholFDA LinkGeneric
10/2021
1DodecanolIBA
10/2021
11-Butanol (n Butanol)IBA
10/2021
11-Octanol (1 Octanol)IBA
10/2021
1Glucagon-Like Peptide-1 ReceptorIBA
12/2019
1LactoferrinIBA
12/2019
1isoborneol (borneol)IBA
12/2019
1Dopamine (Intropin)FDA LinkGeneric
12/2019
1Liposomes (Liposome)IBA
11/2018
1Bevacizumab (Avastin)FDA Link
11/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2018
1Drug CarriersIBA
11/2018
1poly(lactide) (polylactic acid)IBA
11/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2018
1EphrinsIBA
11/2018
1rotigotineFDA Link
01/2018
1Indomethacin (Indometacin)FDA LinkGeneric
12/2014
1EscinIBA
12/2014
1AntioxidantsIBA
12/2014

Therapy/Procedure

1Photothermal Therapy
01/2022
1Intranasal Administration
12/2019
1Microspheres (Microsphere)
12/2019
1Lasers (Laser)
11/2018